Through its Venture Capital unit, Evonik has invested in the start-up NUMAFERM and now holds a minority share in the biotechnology company, which is located in Düsseldorf. The investment was made as part of a seed financing round and also includes investments by High-Tech Gründerfonds, the Business Angels and Qiagen co-founders Detlev Riesner and Jürgen […]
This author has yet to write their bio.Meanwhile lets just say that we are proud numaferm-admin contributed a whooping 30 entries.
Entries by numaferm-admin
Prof. Dr. Andreas Pinkwart, NRW Minister for Economy and Digitization, has visited NUMAFERM as part of “Neue Gründerzeit NRW” on August 17. Pinkwart was given an introduction to the innovative production technology of NUMAFERM that perfectly fits to the idea of bioeconomy. The company, investors, Pinkwart and further participants talked about the importance of life-sciences […]
NUMAFERM is exhibiting at the BIO International Convention in San Diego. Meet us there!
NUMAFERM had the honor to present their technology to over 250 participants at the Dutch Peptide Symposium 2017 in Eindhoven, Netherlands. Click here to reach the symposium website and to see some impressions of the event.
We are presenting at the Chemspec Europe 2017 in Munich. Meet us at the Agro Chemical Lecture Theatre on June 1st!
The Dusseldorf university spin-off NUMAFERM specializes in the biotechnical production of peptides and is able, through its newly developed platform technology, to dramatically reduce costs for this raw material. For the further technological development and an accelerated market entry, NUMAFERM GmbH is now receiving funding in the seven-digit range. High-Tech Gründerfonds (HTGF), Qiagen co-founders and […]
Tel: +49 211 97532901